Project Summary The goal of this proposal is to investigate a novel role of CELF2 in suppressing interferon responses to self- RNA ligands. While interferons (IFN) induced by non-self-viral RNA activate an antiviral program to restrict viral pathogens, their aberrant expression can cause tissue damage leading to autoimmunity. Although the toll-like receptors and RIG-I-like receptors normally sense non-self RNA, these sensors are also activated by self-RNA under certain conditions. Recognition of self-RNA can be a consequence of a failure of the suppression of the self-RNA ligands. RNA editing by ADAR1 is one pathway used to suppress self-RNA ligands, but it is conceivable that there are many other mechanisms that suppress endogenous immunostimulatory RNA ligands. We made a surprising observation that the loss of splicing factor CELF2 induced a robust induction of type I IFN and IFN-stimulated genes. Splicing factors are required for mRNA processing and post- transcriptional regulation, however the effect of aberrant and alternative splicing on IFN responses is understudied. We found that IFN induced during CELF2 depletion is dependent on RIG-I-like receptors. In this proposal, we will identify the mechanisms of CELF2-mediated suppression of IFN activation. CELF2 has not been previously implicated in suppressing immunostimulatory self-RNA ligands. This study will describe a novel role for CELF2 in innate immune signaling, but also study the effect of perturbation of mRNA splicing on innate immunity. This study has the potential to uncover mechanisms of the biogenesis of endogenous RNA that activates the RLR pathway. These findings could have a significant impact on understanding IFN-induced immune pathologies and identify new therapeutic targets in autoimmunity.